Pyrazinamide and Cefuroxime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pyrazinamide (pyrazinamide) and Cefuroxime (cefuroxime sodium). Common drug interactions include aspartate aminotransferase increased among females and cachexia among males.

The phase IV clinical study analyzes what interactions people have when they take Pyrazinamide and Cefuroxime. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Pyrazinamide?

Pyrazinamide has active ingredients of pyrazinamide. It is often used in tuberculosis. eHealthMe is studying from 10,062 Pyrazinamide users. Check the latest studies of Pyrazinamide.

What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.



On Jul, 11, 2026

14 people who take Pyrazinamide and Cefuroxime together, and have interactions are studied.

Pyrazinamide and Cefuroxime drug interactions.

What are the common drug interactions of Pyrazinamide and Cefuroxime, by gender? *:

female:

  1. Aspartate aminotransferase increased
  2. Abortion spontaneous (naturally occurring miscarriage)
  3. Alanine aminotransferase increased
  4. Blood alkaline phosphatase increased
  5. Blood bilirubin increased
  6. Complications of maternal exposure to therapeutic drugs
  7. Drug level decreased
  8. General physical health deterioration (weak health status)
  9. Hepatotoxicity (chemical-driven liver damage)
  10. Multi-organ failure (multisystem organ failure)

male:

  1. Cachexia (loss of weight)
  2. Decreased appetite
  3. Arthralgia (joint pain)
  4. Chest pain
  5. Creatinine renal clearance decreased
  6. Deafness
  7. Dizziness
  8. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  9. Insomnia (sleeplessness)
  10. Myalgia (muscle pain)

What are the common drug interactions of Pyrazinamide and Cefuroxime, by age (0-1 to 60+)? *:

0-1:

  1. Hepatitis (inflammation of the liver)
  2. Immune reconstitution syndrome (immune recovery syndrome)
  3. Lymphadenitis (inflammation or enlargement of a lymph node)

2-9:

  1. Cachexia (loss of weight)
  2. Decreased appetite
  3. Drug ineffective
  4. Gastrointestinal obstruction
  5. Tuberculosis gastrointestinal (a bacterial infection of digestive tract by mycobacterium tuberculosis)
  6. Vomiting

10-19:

n/a

20-29:

  1. Cat scratch disease (bacterial infection by cat scratch)
  2. Abortion spontaneous (naturally occurring miscarriage)
  3. Aspartate aminotransferase increased
  4. Bleeding time prolonged
  5. Blood iron decreased
  6. Complications of maternal exposure to therapeutic drugs
  7. General physical health deterioration (weak health status)
  8. Haematoma (collection of blood outside the blood vessels)
  9. Haematuria present (presence of blood in urine due to trauma)
  10. Haemoglobin decreased

30-39:

  1. Abdominal pain upper
  2. Abdominal tenderness
  3. Arthralgia (joint pain)
  4. Chest pain
  5. Creatinine renal clearance decreased
  6. Deafness
  7. Dizziness
  8. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  9. Insomnia (sleeplessness)
  10. Myalgia (muscle pain)

40-49:

  1. Multi-organ failure (multisystem organ failure)
  2. Pulmonary tuberculosis (lungs tuberculosis)

50-59:

n/a

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Interstitial lung disease
  3. Drug abuse
  4. Drug level decreased
  5. Dyspnoea (difficult or laboured respiration)
  6. Hepatotoxicity (chemical-driven liver damage)
  7. Lung disorder (lung disease)
  8. Pyrexia (fever)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Septic shock (shock due to blood infection)

What are the existing conditions these people have? *

  1. Pneumonia: 6 people, 42.86%
  2. Disseminated Tuberculosis: 4 people, 28.57%
  3. Respiratory Tract Infection: 4 people, 28.57%
  4. Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 14.29%
  5. Vasculitis (inflammation of a blood vessel or blood vessels): 1 person, 7.14%
  6. Interstitial Lung Disease: 1 person, 7.14%
  7. Cd4 Lymphocytes Abnormal: 1 person, 7.14%
  8. Escherichia Infection (bacterial infection by escherichia coli): 1 person, 7.14%
  9. Fever: 1 person, 7.14%
  10. Hiv Infection: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Pyrazinamide and Cefuroxime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pyrazinamide and Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pyrazinamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefuroxime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pyrazinamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefuroxime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pyrazinamide and cefuroxime sodium (the active ingredients of Pyrazinamide and Cefuroxime, respectively), and Pyrazinamide and Cefuroxime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: